scPharmaceuticals Stock Discussion

$scPharmaceuticals(SCPH.US)$
scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease
scPharmaceuticals Inc. (Nasdaq: SCPH)announced that the FDA has accepted their Supplemental New Drug Application (sNDA) to expand FUROSCIXindication to include treatment of edema due to fluid overload in patients with chronic kidney disease (CKD). The FDA has set a PDUFA target action date of March 6, 20...

$scPharmaceuticals(SCPH.US)$
scPharmaceuticals to Present at the Jefferies Global Healthcare Conference
scPharmaceuticals (Nasdaq: SCPH) announced that its CEO, John Tucker, will present at the Jefferies Global Healthcare Conference on June 5, 2024. The presentation will occur at 5:00 PM ET, with Tucker also engaging in meetings with investors throughout the day. The webcast of the presentation will be accessible via the company’s Investor Relations section on its website.

Gainers:
• $Spirit Airlines(SAVE.US)$ +15.8% (JetBlue Urges Spirit Shareholders to Protect Their Interests and 'Vote No' on Frontier Transaction at Upcoming Spirit Special Meeting)
• $scPharmaceuticals(SCPH.US)$ +14% (announces FDA acceptance of FUR.OSCIX new drug application)
• $Rattler Midstream(RTLR.US)$ +12.5% (Diamondback Energy (FANG) agrees to acquire publicly held units of Rattler Midstream)
• $Carvana(CVNA.US)$ +12.7% (the u...